About
Professor Anothy White is a Principal Research Fellow (Senior Group Leader) at QIMR Berghofer, where he leads a group researching cellular processes in neurodegenerative diseases with a focus on developing new human cell models of neurodegeneration.
Dr White received his PhD from Murdoch University (1996) followed by post-doctoral appointments at the University of Melbourne (1996-2001) and Imperial College, London (2001-2003). In 2003, he was appointed at the University of Melbourne (2003-2016) and moved to QIMR Berghofer in 2016.
He has over 175 research publications, obtained over $15 million in competitive research funding and co-founded a start-up biotech company, Procypra Therapeutics. His research has led to the development of first-in-class metal-drugs as a new therapeutic approach to neurodegeneration, leading to a novel copper-based metal-drug currently in clinical trials for motor neuron disease and Parkinson’s disease.
Research Skills
Neurodegenerative diseases, dementia, motor neuron disease, childhood dementia, neuroinflammation, drug development, pluripotent stem cells, microglia, blood-brain barrier.
Area of Interest
Dementia, motor neuron disease, childhood dementia, climate change effects on the brain, bushfire smoke neurotoxicity and neuroinflammation, microglia, blood-brain barrier, olfactory stem cell model, 3D brain cell models, organoids.